# Dutasteride in Enlarged Prostate Economic Assessment: A Retrospective Database Pooled Analysis of Early 5-alpha Reductase Inhibitor Use

> **NCT01332435** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 6896 (actual)

## Conditions studied

- Prostatic Hyperplasia

## Interventions

- **DRUG:** 5ARI + AB

## Key facts

- **NCT ID:** NCT01332435
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 6896 (ACTUAL)
- **Last updated:** 2017-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01332435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01332435, "Dutasteride in Enlarged Prostate Economic Assessment: A Retrospective Database Pooled Analysis of Early 5-alpha Reductase Inhibitor Use". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01332435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*